Glenmede Trust’s DURECT Corp DRRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,600
Closed -$53K 1208
2020
Q4
$53K Buy
2,600
+2,100
+420% +$39.9K ﹤0.01% 1123
2020
Q3
$8K Hold
500
﹤0.01% 1945
2020
Q2
$11K Hold
500
﹤0.01% 1821
2020
Q1
$19K Hold
500
﹤0.01% 2122
2019
Q4
$19K Hold
500
﹤0.01% 2122
2019
Q3
$9 Hold
500
﹤0.01% 2391
2019
Q2
$3 Hold
500
﹤0.01% 2745
2019
Q1
$3 Hold
500
﹤0.01% 2735
2018
Q4
$2 Buy
+500
New +$4.36K ﹤0.01% 2757
2018
Q2
Sell
-500
Closed -$4K 2009
2018
Q1
$4K Hold
500
﹤0.01% 2447
2017
Q4
$4K Hold
500
﹤0.01% 2447
2017
Q3
$8K Sell
500
-100
-17% -$1.68K ﹤0.01% 2237
2017
Q2
$6K Hold
600
﹤0.01% 2237
2017
Q1
$6K Hold
600
﹤0.01% 2237
2016
Q4
$8K Hold
600
﹤0.01% 2147
2016
Q3
$8K Hold
600
﹤0.01% 2177
2016
Q2
$7K Hold
600
﹤0.01% 2173
2016
Q1
$8K Hold
600
﹤0.01% 2100
2015
Q4
$13K Hold
600
﹤0.01% 1985
2015
Q3
$11K Buy
600
+500
+500% +$11.4K ﹤0.01% 2081
2015
Q2
$2K Buy
+100
New +$2.35K ﹤0.01% 2430

Other funds holding DRRX

Glenmede Trust's DRRX Position: Q1 2021 in Review

Glenmede Trust sold out of DURECT Corp (DRRX) in Q1 2021, closing a stake of 2,600 shares — an estimated $53K sold.

Glenmede Trust first reported a position in DRRX in Q2 2015 and held it in 21 quarters. The position peaked at $53K in Q4 2020. 112 funds tracked by Wall St. Rank hold DRRX as of Q1 2021.

  • Glenmede Trust reported no remaining DURECT Corp position as of Q1 2021 after selling out during the quarter.
  • Glenmede Trust sold 2,600 DURECT Corp shares in Q1 2021, an estimated $53K.
  • Glenmede Trust first reported a position in DURECT Corp in Q2 2015 and held it in 21 quarters.
  • Glenmede Trust's DURECT Corp position peaked at $53K in Q4 2020.
  • 112 funds tracked by Wall St. Rank held DURECT Corp as of Q1 2021.

Based on Glenmede Trust's 13F filing for Q1 2021, filed 18 May 2021.